A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.

Author: CoxC E

Paper Details 
Original Abstract of the Article :
Sixty-two patients with complicated urinary tract infections were treated by random allocation with either ceftazidime (0.5 g every 12 h) or tobramycin (3 mg/kg/day). All patients had underlying urological conditions and a urinary tract infection with an organism sensitive to both ceftazidime and to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/jac/12.suppl_a.47

データ提供:米国国立医学図書館(NLM)

Ceftazidime vs. Tobramycin: A Race Across the Desert of Urinary Tract Infections

Urinary tract infections (UTIs) are a common and often troublesome condition. This study explores the efficacy of two antibiotics, ceftazidime and tobramycin, in treating complicated UTIs. The researchers compared the effectiveness of these treatments in a randomized controlled trial, providing valuable insights into the optimal antibiotic choices for managing these infections.

Navigating the Desert of UTIs: A Comparative Study of Antibiotics

The study found that both ceftazidime and tobramycin were effective in treating complicated UTIs, achieving similar cure rates. This research provides evidence-based guidance for healthcare providers in selecting the most appropriate antibiotic for individual patients, helping to ensure optimal treatment outcomes.

The Oasis of Urinary Health: Choosing the Right Antibiotic for UTIs

The study's findings highlight the importance of carefully considering the specific characteristics of a UTI when choosing an antibiotic. Just as a camel carefully chooses its path through the desert, healthcare providers must select the most appropriate antibiotic to ensure a swift and successful treatment journey.

Dr. Camel's Conclusion

This research underscores the importance of evidence-based medicine in guiding antibiotic choices for UTI treatment. Just as a camel navigates the vast desert by following well-worn paths, healthcare providers must rely on scientific evidence to ensure the most effective and safe treatment options for their patients.

Date :
  1. Date Completed 1983-11-23
  2. Date Revised 2019-05-11
Further Info :

Pubmed ID

6352654

DOI: Digital Object Identifier

10.1093/jac/12.suppl_a.47

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.